Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Go back to Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood| Bruker Corporation (NASDAQ: BRKR) | Delayed: 62.14 +0.40 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.74 | 52 Week High | $29.85 | |||
| Open | $62.34 | 52 Week Low | $19.59 | |||
| Day High | $62.75 | P/E | 129.46 | |||
| Day Low | $61.29 | EPS | $0.48 | |||
| Volume | 217,343 | |||||
